Side-by-side comparison of AI visibility scores, market position, and capabilities
Newport News VA nuclear shipbuilding (NYSE: HII) $11.1B FY2024 revenue; sole US aircraft carrier builder, Virginia/Columbia-class submarine partner, CVN-79 JFK delivery, AUKUS submarines competing with General Dynamics.
Huntington Ingalls Industries, Inc. (HII) is a Newport News, Virginia-based defense shipbuilding and defense services company — publicly traded on the New York Stock Exchange (NYSE: HII) as an S&P 500 Industrials component — building and maintaining nuclear-powered submarines (Virginia-class attack submarines, Columbia-class ballistic missile submarines) and surface ships (Gerald R. Ford-class nuclear aircraft carriers, America-class amphibious assault ships, Arleigh Burke-class destroyers) through its Newport News Shipbuilding and Ingalls Shipbuilding subsidiaries, and providing defense technology and services through the Mission Technologies segment, through approximately 44,000 employees. HII is the largest military shipbuilder in the United States and the sole builder of US Navy nuclear-powered aircraft carriers (Newport News Shipbuilding — Gerald R. Ford-class carriers, the USS Gerald R. Ford CVN-78 delivered 2017, USS John F. Kennedy CVN-79 under construction) and a partner with General Dynamics Electric Boat for Virginia-class nuclear submarine construction (Newport News builds the stern, propulsion systems, and integration; Electric Boat builds the bow and performs final integration at Groton CT). In fiscal year 2024, HII reported revenues of $11.1 billion (+5% year-over-year), with the Shipbuilding segment generating $8.6 billion and Mission Technologies (defense IT, analytics, C5ISR services) generating $2.5 billion. CEO Chris Kastner has focused on improving shipbuilding performance metrics (on-time delivery, ship quality scores, learning curve efficiency) as the Newport News Shipbuilding facilities executed multiple concurrent complex programs — CVN-79 John F. Kennedy carrier construction, CVN-80 Enterprise carrier material purchasing, Virginia-class Block V submarine sections — amid post-COVID skilled shipwright workforce shortages and supply chain disruptions.
Indianapolis agricultural seeds and crop protection (NYSE: CTVA) $17.2B FY2024 revenue; Pioneer Hi-Bred seeds, Enlist weed system, Qrome corn traits, competing with Bayer Crop Science and Syngenta.
Corteva, Inc. is an Indianapolis, Indiana-based agricultural science company — publicly traded on the New York Stock Exchange (NYSE: CTVA) as an S&P 500 Materials component — developing and selling seeds (Pioneer brand corn, soybean, sunflower, and vegetable seeds) and crop protection products (herbicides, insecticides, fungicides under Enlist, Instinct, Zorvec, and other brands) to farmers across 140 countries through approximately 22,000 employees. Corteva was spun off from DowDuPont in June 2019 as the agricultural science component of the DowDuPont three-way breakup (materials science → Dow Inc., specialty products → DuPont de Nemours, agriculture → Corteva), combining the Pioneer Hi-Bred seed genetics legacy (acquired by DuPont in 1999 for $9.4 billion) with the Dow AgroSciences crop protection portfolio. In fiscal year 2024, Corteva reported revenues of $17.2 billion, with the Seed segment (corn, soybean, and specialty crop seeds) generating $9.3 billion and the Crop Protection segment (pesticides, herbicides, fungicides) generating $7.9 billion — though crop protection faced market headwinds from generic agrochemical price competition and grower inventory destocking as global commodity crop prices fell from 2022-2023 peaks. CEO Chuck Magro's strategy focuses on driving pricing power through genetic trait performance (Corteva's Qrome corn trait technology delivering 5-10 bushel/acre yield advantage driving premium seed pricing) and the Enlist weed control system (herbicide-tolerant soybeans paired with Enlist Duo herbicide through a closed IP system that bundles herbicide and trait royalty revenue).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.